Recent Updates
Recently added Catalysts
CLNN Positive Sentiment

Clene to Present at Upcoming October Conferences

Wednesday, October 9, 2024 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Clene Inc. has announced its participation in two upcoming investor conferences in October 2024. The company will present at the Maxim Healthcare Virtual Summit from October 15-17 and at the ThinkEquity Conference on October 30, both aimed at promoting its advancements in treating neurological diseases. These presentations will include both fireside chats and one-on-one meetings, allowing for direct engagement with potential investors. Clene's focus on mitochondrial health and neuronal function underlines its commitment to innovative biopharmaceutical solutions.
Price reaction · baseline $5.13 (2024-10-08 close) · hit after-hours · clean, no other CLNN news in the window
day 0 close · peak
+14%
day 1
+7.4%
day 3
+12.1%

Market Sentiment Analysis

POSITIVE FACTORS

  • Clene Inc. is actively engaging with investors at upcoming conferences.
  • The company's focus on neurological diseases highlights its innovative research initiatives.
  • Participation in prestigious events like Maxim Healthcare and ThinkEquity can elevate Clene's visibility.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+63%
120-day peak, hindsight
Typical move
5.3%
average across 6 past catalysts
Cash runway
~11 mo
Medium dilution risk
Lead asset
CNMAu8
Phase 2 · Amyotrophic Lateral Sclerosis

Full Press Release Details

SALT LAKE CITY, Oct. 09, 2024 (GLOBE NEWSWIRE) -- Clene Inc. (Nasdaq: CLNN) (along with its subsidiaries, “Clene”) and its wholly owned subsidiary Clene Nanomedicine Inc., a clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurological diseases, including amyotrophic lateral sclerosis (ALS) and multiple sclerosis (MS), today announced that it will participate in the following investor conferences in October.
2024 Maxim Healthcare Virtual Summit
Date: October 15-17, 2024
Presentation: October 15, 2024, at 2:30 p.m. E.T.
Format: Fireside Presentation and 1x1 meetings
Attendance: Sign up to become an M-Vest member
The ThinkEquity Conference 2024
Dates: October 30, 2024
Location: New York, New York, Mandarin Oriental Hotel
Presentation: October 30, 2024, at 3:30 p.m. E.T.
Format: Presentation and 1x1 meetings
Webcast Link: https://wsw.com/webcast/tep25/clnn/1673136

Frequently Asked Questions

What is Clene Inc. focused on?

Clene Inc. aims to improve mitochondrial health and protect neuronal function.

What neurological diseases does Clene target?

Clene is focused on treating ALS and multiple sclerosis (MS).

When is Clene participating in the Maxim Healthcare Summit?

Clene will participate in the summit from October 15-17, 2024.

Where will The ThinkEquity Conference 2024 be held?

The conference will take place at the Mandarin Oriental Hotel, New York.

How can I watch Clene’s presentation at ThinkEquity Conference?

You can watch the presentation via the provided webcast link.

ShareAdd on Google
Tags: CLNN Viatris Investor Conferences Healthcare Clene Inc. neurological diseases October conferences investor relations
Last updated: Oct 9, 2024

Biotech snapshot

Cash runway
$10M liquidity · $1M/mo burn
~11 mo
Medium dilution risk
Lead asset
CNMAu8Phase 2
Amyotrophic Lateral Sclerosis →

Catalyst track record

+63%
best trade around CLNN's most recent catalyst

Peak hindsight return over a 120-day window, across 6 tracked FDA/PDUFA catalysts for CLNN.

See every catalyst's timing & PoA →